During the past decade, Konkuk University Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Konkuk University Medical Center" are "Postoperative Nausea" (2 trials), "Alzheimer Disease" (1 trials), "Ambulatory Surgery" (1 trials), "Brain Diseases" (1 trials) and "Central Nervous System Diseases" (1 trials). Many other conditions were trialed in "Konkuk University Medical Center" in a lesser frequency.

Most popular intervention types in "Konkuk University Medical Center" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ammonium Glycyrrhizinate" (1 trials), "Baricitinib" (1 trials), "CartiZol" (1 trials) and "Donanemab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Konkuk University Medical Center" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Konkuk University Medical Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Konkuk University Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Konkuk University Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".